Predicting Adverse Drug-Drug Interactions with Neural Embedding of Semantic Predications.

Journal: AMIA ... Annual Symposium proceedings. AMIA Symposium
PMID:

Abstract

The identification of drug-drug interactions (DDIs) is important for patient safety; yet, compared to other pharmacovigilance work, a limited amount of research has been conducted in this space. Recent work has successfully applied a method of deriving distributed vector representations from structured biomedical knowledge, known as Embedding of Semantic Predications (ESP), to the problem of predicting individual drug side effects. In the current paper we extend this work by applying ESP to the problem of predicting polypharmacy side-effects for particular drug combinations, building on a recent reconceptualization of this problem as a network of drug nodes connected by side effect edges. We evaluate ESP embeddings derived from the resulting graph on a side-effect prediction task against a previously reported graph convolutional neural network approach, using the same data and evaluation methods. We demonstrate that ESP models perform better, while being faster to train, more re-usable, and significantly simpler.

Authors

  • Hannah A Burkhardt
    University of Washington, Seattle, WA.
  • Devika Subramanian
    Rice University, Houston, Texas.
  • Justin Mower
    Baylor College of Medicine, Houston, Texas;; University of Texas Health Science Center at Houston, Houston, Texas.
  • Trevor Cohen
    University of Washington, Seattle, WA.